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SUMMARY
The occurrence of Anaplasma phagocytophilum was investigated in spleen and serum samples
from Swedish moose (Alces alces) in southern Sweden (island and mainland). Samples were
analysed for presence of A. phagocytophilum DNA by real-time PCR (n=263), and for
Anaplasma antibodies with ELISA serology (n=234). All serum samples had antibodies against
A. phagocytophilum. The mean DNA-based prevalence was 26·3%, and signiﬁcant (P<0·01)
temporal, and spatial variation was found. Island moose had signiﬁcantly (P<0·001) higher
prevalence of A. phagocytophilum DNA than moose from the mainland areas. Two samples were
sequenced to determine genetic variation in the 16S rRNA and groESL genes. Genetic sequence
similarity with the human granulocytic anaplasmosis agent, equine granulocytic ehrlichiosis
agent, and different wildlife-associated A. phagocytophilum variants were observed in the 16S
rRNA and groESL genes. Our study shows that moose are exposed to A. phagocytophilum in
Sweden, and represent a potential wildlife reservoir of the pathogen.
Key words: Ehrlichia, epidemiology, HGA, moose, PCR, serology, tick-borne fever.
INTRODUCTION
Anaplasma phagocytophilum is a widespread tick-
borne pathogen reported to infect various species
of wild and domestic animals [1]. It is a
Gram-negative, obligate intracellular bacterium of
the order Rickettsiales that infects white blood cells
(neutrophils, eosinophils, monocytes). The primary
vectors are ticks including Ixodes ricinus (Europe
[1]), Ixodes scapularis (eastern United States), and
Ixodes paciﬁcus (western United States) [2]. In cattle
and sheep, A. phagocytophilum infection can cause
tick-borne fever (TBF), a disease characterized by
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fever, depression, lethargy, reduced milk yield (dairy
cattle) and abortion [1]. In horses, infection with
A. phagocytophilum (earlier known as Ehrlichia equi)
may cause equine granulocytic ehrlichiosis [3], and
in humans it is a cause of human granulocytic ana-
plasmosis (HGA [4]). HGA is considered to be an
emerging vector-borne infection in Europe [5] and
the USA [5, 6], and is reportedly under-diagnosed
due to the similarity of its clinical symptoms with
infection with Borrelia burgdorferi [6].
The epidemiology of A. phagocytophilum in
wildlife is poorly understood, and few reports on the
pathogenic potential of A. phagocytophilum infection
in cervids exist. These include case reports of
A. phagocytophilum-associated mortality in roe deer
(Capreolus capreolus) fawns and a moose calf (Alces
alces) from Norway [7–9]. In these reports, the ani-
mals succumbed due to a fatal, presumably secondary
bacterial pneumonia, and the authors suggested that
the immunosuppressive effects of a primary infection
with A. phagocytophilum may have facilitated the
lung infection. Seroprevalence in moose was reported
to be 43% in a study in Norway [10], but associa-
tion with disease was not investigated. Another
Norwegian study reported a 79% seroprevalence in
moose from a habitat know to be tick-infested [11].
Different genetic variants of A. phagocytophilum
have been found in cervids based on 16S rRNA
gene sequencing [12–14]. Red deer (Cervus elaphus)
in the Czech Republic reportedly carry two different
16S rRNA variants of A. phagocytophilum [15].
However, sequences of other less conserved genes
such as msp4, groESL or anka from different A. pha-
gocytophilum isolates revealed substantial variability
[16–19]. For instance, up to 11 different variants of
A. phagocytophilum based on the groESL gene
sequences were detected in roe deer, red deer, alpine
chamois (Rupicapra rupicapra), Alpine ibex (Capra
ibex), and European mouﬂon (Ovis musimon) in
Austria [13].
In 2005, a dead moose calf from the island of Öland
in the Baltic Sea (Fig. 1) was submitted for
Fig. 1. Map showing sampling areas (highlighted) in Sweden. A represents the island of Öland; B, C, and D represent
sampling areas in three different mainland populations.
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post-mortem examination to the National Veterinary
Institute in Uppsala, Sweden. The cause of death
was a severe bacterial bronchopneumonia, with a con-
current septicaemia (caused by Streptococcus sp.).
A. phagocytophilumDNAwas detected by polymerase
chain reaction (PCR) analysis [20]. It was suggested
that the A. phagocytophilum infection facilitated the
bacterial bronchopneumonia, resembling the ﬁndings
of the report from Norway [7]. On the island of
Öland local hunters have since 2006 reported low
numbers of observed moose calves during the autumn
hunt [21]. Several hunters on the island are also farm-
ers (sheep, cattle), and frequently observe and treat
their animals for tick-borne fever; similar information
has been reported by local veterinarians [22]. Hence, it
was suggested that infection with A. phagocytophilum
had affected moose calf health and survival on the
island.
The epidemiology of A. phagocytophilum infection
in moose populations based on both serological and
PCR-based data has not been reported previously.
The aim of the present study was to investigate the
serological and DNA-based prevalence of A. phagocy-
tophilum in hunter-harvested moose from the island of
Öland, and three areas on the mainland of Sweden.
MATERIALS AND METHODS
Samples from harvested moose were collected from
the island of Öland (Fig. 1, area A; 2007–2010), and
from three mainland populations (Fig. 1, areas B, C,
D; 2008–2010) during the moose hunt in October
and November. Area A, the island of Öland, is a habi-
tat with a mix of agricultural land and deciduous for-
est in the southern part, and boreal forest in the
northern parts. Areas B, C, and D consist of mostly
boreal forest [23]. Trained ﬁeld assistants collected
fresh samples (spleen, kidney, liver, faeces, lower
jaws, ectoparasites, rumen contents, blood) from har-
vested moose, according to a standardized protocol.
Blood (primarily from vena cava caudalis or the
heart) was collected in non-additive blood tubes (BD
Vacutainer®, BD Diagnostics, USA). Serum was sep-
arated from the blood samples and stored at −20 °C.
A 4×4 cm piece of the spleen, mandibles, and remain-
ing samples were stored at −20 °C awaiting further
analysis. The body condition (below normal or nor-
mal) based on the presence of coronary fat deposits
and signs of muscular atrophy, was recorded, and
a speciﬁc identity was assigned to each sampled
moose. The hunters recorded the weight of the carcass
after removal of skin, head, internal organs, and meta-
podials, according to Wallin [24].
For age determination in adult moose, the ﬁrst
molar of the lower jaw was sectioned and cementum
layers counted as described by Wolfe [25]. The ani-
mals were divided into three age groups: calf
(<1 year), subadult (1–2 years), and adult (>2 years).
The screening for presence of A. phagocytophilum
DNA was performed with a diagnostic commercial
real-time PCR test for detection of 16S rDNA using
GER3 (TAGATCCTTCTTAACGGAAGGGCG)
and GER4 (AAGTGCCCGGCTTAACCCGCTG-
GC) primers as described by Goodman et al. [26], but
converted to a real-time PCR format by adding a Taq-
Man probe [27]. Total DNAwas extracted from spleen
samples, excising a cube with sides of 0·5 cm, mashing
the tissue with sterile scalpels, subsequently followed
by lysis andDNA extraction according to themanufac-
turer’s instructions, using the QIAamp DNA Extrac-
tion kit and an EZ1 BioRobot (Qiagen GmbH,
Germany). PCRwasperformed according to Jäderlund
et al. [27] in an ABI 7500 FAST PCR machine (Life
Technologies, USA), and was run for 40 cycles. Each
PCR included a control with the DNA template substi-
tuted with sterile water, a positive and a negative refer-
ence A. phagocytophilum template, extracted from
blood from A. phagocytophilum-infected and non-
infected horses, respectively. To prevent contamination
from environmental DNA, the preparation of PCR
mixtures, DNA extraction, PCR and detection of
products were all performed in separated laboratory
facilities, and aerosol-resistant ﬁlter pipette tips were
used throughout the experiment.
Of the 10 spleen samples submitted for genetic
sequencing, direct sequencing using GER3 and
GER4 primers for 16S rDNA, yielded good quality
sequences without the need for cloning for two
samples (915 bp), one from a mainland moose and
one from an island moose. From these two samples
also partial groESL sequences were obatined (1275
bp). The PCR and sequencing protocol used was iden-
tical to that used by Franzén et al. [28].
For detection of Anaplasma antibodies, an immu-
noﬂuorescence assay (IFA) was used [27]. Brieﬂy, two-
fold dilutions of sera were added to slides precoated
with A. phagocytophilum antigen (Protatek, USA).
To visualize the bound antibodies, a ﬂuorescein iso-
thiocyanate (FITC)-conjugated rabbit anti-deer IgG
(KP Laboratories, USA) was added and slides were
examined by ﬂuorescence microscopy. For negative
control, a seronegative moose sample was used, and
Anaplasma phagocytophilum in moose 1207
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0950268813002094
Downloaded from https://www.cambridge.org/core. Scotland’s Rural College (SRUC), on 02 Jul 2019 at 13:01:16, subject to the Cambridge Core terms of use, available at
for a positive control the opposite. All samples were
screened at a dilution of 1:40. For further titration,
77 high-quality (minimal hemolysis) serum samples
from 2009 and 2010 were selected (51 from area A,
26 from areas B, C, D). These samples were further
titrated in twofold steps to a dilution of 1:1280. An
IFA titre 51:40 was considered positive, in accord-
ance with Stuen et al. [10]. A further titration of
samples with titres 1:1280 was not performed.
Statistical analyses of risk factors affecting PCR
presence of A. phagocytophilum were performed
using logistic regression in R (R Foundation for
Statistical Computing, Austria). An exploratory
analysis using multiple possible risk factors was con-
ducted (Table 1). Crude and adjusted odds ratios
(OR) with 95% conﬁdence intervals were calculated
to identify which factors (sampling area, sex, sampling
year, age group, carcass weight) were associated with
higher or lower PCR presence of A. phagocytophilum.
The crude OR is an estimation of one speciﬁc factor
without consideration and possible confounding
effects of other factors. The adjusted OR is estimated
with consideration of other factors (stated previously)
included in the model. In addition, statistical
signiﬁcance calculations (P values) between sampling
area, sex, sampling year, age group, and carcass
weight (in relation to age group) were performed
using Wald’s test within the same logistic regression,
as seen in Table 1.
RESULTS
Spleen samples from 263 harvested moose (141
females, 122 males) were collected (Table 2). Blood
was obtained from a total of 234 moose. From the
remaining 29 moose, blood could not be collected,
mostly due to contamination by rumen contents, or
an insufﬁcient collectable volume that occurred
when the moose had been eviscerated prior to
sampling by ﬁeld assistants. Mean carcass weight for
calves (n=73) was 60·5 kg (range 25–87 kg), for sub-
adults (n=57) 127·3 kg (range 75–180 kg), and for
adults (n=109) 193·1 kg (range 118–302 kg). For 24
moose, no carcass weight was reported by the hunters.
Twelve moose were found to be in subnormal body
condition, and of these, clinical signs of disease
(emaciation of unknown cause) were observed in
Table 1. Results of a logistical regression model with factors associated with PCR-based detection of Anaplasma
phagocytophilum in Swedish moose (Alces alces) spleens
Variable
Crude OR*
(95% CI)
Adjusted OR†
(95% CI)
P
(Wald’s test)‡
P
(LR test)§
County Ref.: A (Öland) 1 1 0·001
B (Småland) 0·82 (0·19–3·62) 1·45 (0·26–8·2) 0·675
C (Sörmland) 0·36 (0·08–1·70) 0·37 (0·06–2·23) 0·276
D (V-Götland) 0·11 (0·01–0·84) 0·19 (0·02–1·75) 0·141
Sex Male vs. female 1·26 (0·69–2·28) 0·94 (0·44–1·99) 0·869 0·869
Year Ref.: 2007 1 1 <0·001
2008 9·84 (2·21–43·86) 19·57 (3·91–97·93) <0·001
2009 1·99 (0·41–9·77) 4·73 (0·88–25·49) 0·07
2010 9·43 (1·95–45·66) 28·93 (5·17–162·05) <0·001
Age group Ref.: calf 1 1 0·485
Yearling 0·22 (0·09–0·53) 0·26 (0–73·48) 0·637
Adult 0·35 (0·18–0·7) 0·1 (0–5·48) 0·263
Carcass weight 0·99 (0·99–1·00) 0·99 (0·95–1·02) 0·464 1
Age group: carcass weight Ref.: calf 1 1 0·716
Yearling — 1·00 (0·95–1·06) 0·858
Adult — 1·01 (0·98–1·05) 0·495
OR, Odds ratio; CI, conﬁdence interval; LR, likelihood ratio.
* The OR of one speciﬁc factor without consideration of confounding effects of other factors.
†The OR of one factor, with consideration of confounding effects of other factors.
‡The P value based on the sample estimate.
§ Likelihood ratio test.
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two moose. The mean age of sampled moose was
2·8 years (range 0·5–15·5).
The overall prevalence of A. phagocytophilum
DNA was 26·3%. On a spatial scale, moose from
area A (island) had a signiﬁcantly (P<0·006) higher
prevalence of A. phagocytophilum DNA (36·6%)
than the combined prevalence in moose from areas
B, C, and D (15·9%). The area variable was highly
signiﬁcant (likelihood ratio test P<0·01), indicating
signiﬁcant spatial heterogenity of A. phagocytophilum
prevalence. Area A (island) had the highest recorded
prevalence, 36·6%, and area C had the lowest recorded
prevalence of 7·9%. No signiﬁcant difference in
prevalence (P=0·141–0·657, Table 1) between individ-
ual counties was found. Regardless of sampling
areas, samples from 2008 and 2010 had signiﬁcantly
(P<0·01) higher A. phagocytophilum DNA preva-
lence than samples collected in 2007 (Table 1) and
2009 (results from separate model using 2009 as refer-
ence, not shown). For all moose samples from 2007 to
2010, sex, age group, and age did not have signiﬁcant
effects on the presence of A. phagocytophilum DNA.
All tested samples were serologically positive
(titre 51:40). Titration was performed on 77 samples
from 2009 and 2010, with titres ranging from 1:40
to 1:1280. Figure 2 shows an overview of serological
titres related to presence of A. phagocytophilum
DNA. An additional model ﬁtted to a subset of
77 animals that included A. phagocytophilum titre
levels (results not shown) indicated no signiﬁcant
predictive effect of titre levels, but a signiﬁcant
effect (P<0·001) of body weight when controlled
for age.
The genetic sequencing revealed a 99% sequence
similarity between the two samples for the 16S
rRNA part. Furthermore, the island sample had 16S
rRNA sequence similarities with an equine variant
previously detected in Sweden (GenBank accession
no. AY527214; 912/915 bp, 99·7%) [27], a roe deer
sequence from Austria (496/497 compared base
pairs, 99·8%, GenBank accession nos. FJ812391–
FJ81239 (type S) [13]). The groESL sequence from
the island moose had a 99% sequence similarity
(1267/1275 compared base pairs) with an HGA
agent detected in humans in California (GenBank
accession no. AF172163 [29]), unlike the mainland
sample which shared 1252/1276 bp with the HGA
agent (98·6%). Furthermore, the island groESL
sequence was similar to a red deer and a roe deer
sequence from Austria (530 bp compared, 99·6% and
Table 2. Geographical and biological distribution, and
numbers of Anaplasma phagocytophilum
DNA-positive samples in moose spleen samples from
Sweden collected from 2007 to 2010
Variable
No. of
samples
A. phagocytophilum
DNA positive (%)
Sampling area* 48 (36·6)
A (Öland) 131 15 (17·6)
B (Småland) 85 3 (7·9)
C (Sörmland) 38 3 (33·3)
D (Västergötland) 9
Sex
Male 141 34 (24·1)
Female 122 35 (28·7)
Year
2007 35 4 (11·4)
2008 90 33 (36·7)
2009 90 14 (15·6)
2010 48 18 (37·5)
Age group†
Calf 81 37 (45·7)
Yearling 66 10 (15·2)
Adult 113 22 (19·5)
Not recorded 3 0
Overall 263 69 (26·2)
* Four different counties in southern Sweden according to
Figure 1.
† Sampled moose divided in to three age groups: 0–1 year,
1–2 years, and >2 years.
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Fig. 2. An overview of numbers of samples with antibody
titres and DNA presence of Anaplasma phagocytophilum
in Swedish moose (Alces alces) sampled in 2009 and 2010.
n.a., Not available.
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99·4% sequence similarity, respectively, GenBank
accession nos. GQ988767 and GQ988765, respect-
ively) [13].
The 16S rRNA sequence from the mainland
moose sample had a 99·9% sequence similarity with
the equine variant reported previously from Sweden
(GenBank accession no. AY527214; 914/915 bp [27],
and was identical (497/497 compared base pairs) to
an Austrian roe deer sequence (GenBank accession
nos. FJ812406–FJ812408, type Y) [13]. A shorter
section (groEL) of the groESL gene sequence in the
mainland moose sample showed a 100% sequence
similarity (455/455 bp) with a roe deer A. phagocyto-
philum sequence detected in Austria (Gen Bank acces-
sion no. GQ988754), and a 99·8% sequence similarity
(529/530 bp) with sequences found in both red deer
and roe deer in the same paper [13] (GenBank acces-
sion no. GQ988763).
GenBank accession numbers for the novel moose
sequences are KC800983 (island) and KC800984
(mainland) for the 16S rRNA sequences and
KC800985 (island) and KC800986 (mainland) for
the groESL sequences.
DISCUSSION
This is the ﬁrst study on A. phagocytophilum infection
in moose in Sweden, based on the presence of A. pha-
gocytophilum DNA, and of antibodies. No similar
large-scale study in cervids has previously been
reported, apart from a Norwegian study of archived
moose serum samples (collected 1994–2000), where a
43% seroprevalence in moose was found [10]. In
2012 seroprevalence of A. phagocytophilum antibodies
in 33 captured moose from a reported tick-infested
area in southern Norway was 78% [11]. Although
the performance of the serological test in moose has
not been validated, we consider the results to be
reliable since the test used in three Norwegian studies
[10, 11, 30] is the same as the one used in this study.
In addition, there are no reports of possible cross-
reacting Anaplasma variants (e.g. A. marginale) in
Sweden.
In the present study the overall prevalence of
A. phagocytophilum DNA was 26·3%, with signiﬁcant
spatial difference between the island population (A)
and the mainland populations (B, C, D). Spatial vari-
ation in prevalence of vector-borne pathogens has
been described previously. Chaput et al. [31] reported
spatial variation in incidence of the HE agent in
humans in Connecticut, USA. In the present study,
one reasonmight be the annual arrival of high numbers
of tick-carryingmigrating birds, which reportedly carry
Ehrlichia sp. bacteria (HE agent [32]). DNA in the pre-
sent study also showed a temporal difference, with
higher prevalence in 2008 and 2010, respectively.
Temporal variation in A. phagocytophilum antibody
prevalence has previously been reported by Rejmanek
et al. [33] in small mammals in California where the
rate of exposure (antibody presence) varied over a
2·5-year period.
The range in A. phagocytophilum antibody titres
(1:40–1:1280) observed, may be a result of several
factors including the time of infection/exposure,
re-infection, host immune response, variant of the
bacterium, cyclic bacteraemia in the infected animal,
and the sensitivity of the detection method [16, 34].
Antibodies against different Anaplasma variants have
been shown to persist for at least 5 months in exper-
imentally infected dogs (Ehrlichia sp. [35]), lambs
(A. phagocytophilum [36]) and horses (Ehrlichia
phagocytophila [37]), and for at least 2·5 months in
red deer [30].
The observed effect of A. phagocytophilum DNA
presence on moose carcass weight described earlier
in this report will not be further commented upon
due to the small sample size (n=77).
A 42·6% A. phagocytophilum DNA prevalence has
been reported previously in 237 sampled roe deer in
Denmark [38]. Other European studies have shown
varying A. phagocytophilum DNA prevalence ranging
from 18% to 86% (roe deer [12–15, 39, 40]), 29–86%
(red deer [12, 13, 40, 41]), 50–72% (fallow deer,
Dama dama [15, 42]), and 40% (sika deer, Cervus nip-
pon [15]). These reports suggest that infection with
A. phagocytophilum is common in cervids in Europe.
However, more knowledge is needed about the patho-
genesis, immune response, and clinical manifestation
of A. phagocytophilum infection in order to assess
the clinical and pathological signiﬁcance of infection
in free-ranging cervids such as moose. Experimentally
infected Norwegian captive red deer (Cervus elaphus
atlanticus) and reindeer (Rangifer tarandus) showed
individual differences in clinical signs, time of sero-
conversion, and duration of antibody titre [30, 43].
In reindeer, fever and neutropenia were noted, but
not in red deer, other than a calf which showed a
moderate increase in rectal temperature.
In the present study, antibodies against A. phagocy-
tophilum were found in both A. phagocytophilum
DNA-positive, and DNA-negative moose. The vary-
ing titres (1:40–1:1280) is an indication of when in
1210 J. Malmsten and others
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time the animal is infected, or re-infected. Adding to
this, no end-titration was performed which could
have rendered even higher titres in some samples.
Presumably, and as observed in sampled moose, the
vectors (ticks) are probably active not only in the sum-
mer months but also during the autumn. Antibodies
are reportedly known to persist longer than circulating
bacteria, which could explain the observed discre-
pancy between seroprevalence and A. phagocytophi-
lum DNA-based prevalence. This has been reported
in a various A. phagocytophilum-infected ruminants
including sheep [36, 44] and horses [45]. Similar
discrepancies have previously been reported in roe
deer, where Zeman & Pecha [15] showed a 100%
seroprevalence, and a 30% A. phagocytophilum
DNA-based prevalence. In the same study, the discre-
pancy in mouﬂon was 100% and 3·5%, respectively. In
wild boar from Slovenia, the discrepancy was 72%
(serology) and 6·2% (PCR), respectively [40].
No association between antibody titre and A. pha-
gocytophilum DNA presence was identiﬁed in this
study (Fig. 2). Infection and host humoral immune
response may be dependent on several factors, as
stated previously. For instance, Stuen et al. [46]
reported that experimentally infected lambs had a
detectable bacteraemia on several different occasions
over a 13-week period. In the present study, both
mainland and island moose had been exposed to
A. phagocytophilum, but the A. phagocytophilum
DNA prevalence varied between areas, and between
sampling years (Table 1). A cyclic variation may
also be present in moose infected with A. phagocyto-
philum, and if sampled on another occasion, such as
during the summer months, the A. phagocytophilum
DNA presence, and antibody prevalence, may have
been different. The signiﬁcance of body weight on
the presence of A. phagocytophilum DNA was noted,
and could be caused by a reduced weight gain, as
reported by Stuen et al. [47] in lambs infected on
pasture. However, since this effect was not present in
all sampled moose (sampled from 2007 to 2010), no
conclusions have been drawn.
The results of the genetic sequencing A. phagocyto-
philum DNA-positive samples provide no evidence
that moose are a host or a reservoir for different gen-
etic variants. One of the sequenced samples from an
island moose had genetic similarities with the HGA
agent, which has previously been reported in Sweden
[5, 48]. More spleen samples from moose need to
be sequenced before any further conclusions can be
drawn.
In conclusion, this study demonstrated that moose
from southern Sweden were commonly exposed to
and infected with A. phagocytophilum. The A. phago-
cytophilum DNA prevalence varied between years
(temporal variation) and between regions (spatial
variation). Future studies should focus on the charac-
terization of different genetic variants of A. phagocy-
tophilum in free-ranging Swedish moose, and their
pathogenic potential for moose and other mammalian
species, such as domestic animals and humans.
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